Assignee
PROMENTIS PHARM INC
US·6 granted patents·5 pending applications·20 citations·filing 2013–2023
Top patents by PatentIndex Score
11 records- 0189US10961187B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2019·Granted Mar 30, 2021·1 cites·24 claims
- 0289US2024059649A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2023·Application pending·0 cites
- 0388US9012674B1Ethyl (2R)-2-acetamido-3-(4-methylbenzoylsulfanyl)propanoate and uses thereofPROMENTIS PHARM INC·Filed 2014·Granted Apr 21, 2015·7 cites·3 claims
- 0487US10112897B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2017·Granted Oct 30, 2018·4 cites·60 claims
- 0586US9630937B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2014·Granted Apr 25, 2017·5 cites·60 claims
- 0685US10358414B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2017·Granted Jul 23, 2019·3 cites·21 claims
- 0778US2021395194A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2021·Application pending·0 cites
- 0862US9193681B1Propionic acids, propionic acid esters, and related compoundsPROMENTIS PHARM INC·Filed 2014·Granted Nov 24, 2015·0 cites·9 claims
- 0954US2015045312A1Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X SyndromePROMENTIS PHARM INC·Filed 2014·Application pending·0 cites
- 1050US2013338165A1Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's DiseasePROMENTIS PHARM INC·Filed 2013·Application pending·0 cites
- 1149US2014121202A1S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDSPROMENTIS PHARM INC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →